An approach to target joint bleeding in hemophilia: Prophylaxis for all or individualized treatment?

Journal of Pediatrics

Volumn 145, Issue 5, 2004, Pages 581-583

  Abshire, Thomas ^a,b  

^a AFLAC   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8;

CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; EDITORIAL; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEMARTHROSIS; HEMOPHILIA; HUMAN; INFECTION; LONG TERM CARE; MEDICAL EXAMINATION; MEDICAL INFORMATION; PATIENT; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SIDE EFFECT; SYNOVECTOMY; SYNOVIUM; THROMBOSIS; TREATMENT FAILURE;

CHILD; CHILD, PRESCHOOL; FACTOR IX; FACTOR VIII; HEMARTHROSIS; HEMOPHILIA A; HUMANS;

EID: 7444270966     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.08.040     Document Type: Editorial

References (11)

1. M. Kern, V. Blanchette, A.M. Stain, T.R. Einarson, and B.M. Feldman Clinical and cost implications of target joints in Canadian boys with severe hemophilia A J Pediatr 145 2004 628 634
2. L.M. Aledort, R. Haschemeyer, H. Pettersson, and Group TOOS A longitudinal study of orthopaedic outcomes for serve factor-VIII-deficient haemophiliacs J Int Medicine 236 1994 391 399
3. R.J. Hirschman, S.B. Itscoitz, and N.R. Shulman Prophylactic treatment of factor VIII deficiency Blood 35 1970 189 194
4. A. Aronstam, P.G. Arblaster, S.G. Rainsford, P. Turk, M. Slattery, and M.R. Alderson Prophylaxis in haemophilia: a double-blind controlled trial Br J Haematol 33 1976 81 90
5. K. Fischer, J.G. van der Bom, E.P. Mauser-Bunschoten, G. Roosendaal, R. Prejs, and P. de kleijn The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia Blood 99 2002 2337 2341
6. I.M. Nilsson, E. Berntorp, T. Lofqvist, and H. Pettersson Twenty-five years' experience of prophylactic treatment in severe haemophilia A B. J Intern Med 232 1992 25 32
7. V.S. Blanchette, G.E. Rivard, S.J. Israels, K.S. Robinson, P.S. Babyn, and M.J. McLimont Musculoskeletal results from the Canadian hemophilia dose-escalation prophylaxis trial Blood 102 2003 52a
8. J. Astermark, P. Petrini, L. Tengborn, S. Schulman, R. Ljung, and E. Berntorp Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized Br J Haematol 105 1999 1109 1113
9. V.S. Blanchette, M. McCready, C. Achonu, M. Abdolell, G. Rivard, and M.J. Manco-Johnson A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres Haemophilia 9 suppl 1 2003 19 26
10. V.E. Price, M. Carcao, B. Connolly, P. Chait, A. Daneman, and M. Temple A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia J Thromb Haemost 2 2004 737 742
11. A.L. Dunn, M.T. Busch, J.B. Wyly, K.M. Sullivan, and T.C. Abshire Arthroscopic synovectomy for hemophilic joint disease in a pediatric population J Pediatr Orthop 24 2004 414 426